nitrates has been researched along with pioglitazone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honda, H; Iwata, T; Notoya, Y; Shibusawa, Y; Taniguchi, J | 1 |
| Charbonnel, B; Erdmann, E; Spanheimer, R | 1 |
| Everett, CJ; King, DE; Player, M | 1 |
| Burgin, K; Daiber, A; Gori, T; Hausding, M; Jansen, T; Jurk, K; Knorr, M; Kröller-Schön, S; Münzel, T; Oelze, M; Pfeffer, A; Sartor, D; Scherhag, A; Schulz, E; Schwierczek, K; Wenzel, P | 1 |
| Jain, S; Sharma, B | 1 |
| Ekladious, ST; El Sayed, NS | 1 |
2 trial(s) available for nitrates and pioglitazone
| Article | Year |
|---|---|
Pioglitazone and the risk of cardiovascular events in patients with Type 2 diabetes receiving concomitant treatment with nitrates, renin-angiotensin system blockers, or insulin: results from the PROactive study (PROactive 20).
Topics: Age of Onset; Aged; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Edema; Female; Heart Failure; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Ischemia; Nitrates; Pioglitazone; Thiazolidinediones | 2010 |
The impact of pioglitazone on ADMA and oxidative stress markers in patients with type 2 diabetes.
Topics: Academic Medical Centers; Arginine; Biomarkers; Cross-Over Studies; Diabetes Mellitus, Type 2; Dinoprost; F2-Isoprostanes; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Nitrates; Nitrites; Oxidative Stress; Pioglitazone; Prospective Studies; South Carolina; Thiazolidinediones; Time Factors; Treatment Outcome | 2012 |
4 other study(ies) available for nitrates and pioglitazone
| Article | Year |
|---|---|
Alteration in endothelial function and modulation by treatment with pioglitazone in rabbit renal artery from short-term hypercholesterolemia.
Topics: Acetylcholine; Animals; Biological Factors; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Eicosanoids; Endothelium, Vascular; Enzyme Inhibitors; Hypercholesterolemia; Hypoglycemic Agents; Indomethacin; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitrates; Nitrites; Nitroarginine; Phenylephrine; Pioglitazone; Potassium Channel Blockers; Potassium Chloride; Rabbits; Renal Artery; Thiazolidinediones; Vasoconstrictor Agents; Vasodilator Agents | 2005 |
In vitro and in vivo characterization of a new organic nitrate hybrid drug covalently bound to pioglitazone.
Topics: Animals; Aorta; Bleeding Time; Blood Platelets; Fibrinolytic Agents; Humans; Hypoglycemic Agents; Male; Mice, Inbred C57BL; Mitochondria, Heart; Nitrates; Pioglitazone; Platelet Aggregation; Rats, Wistar; Reactive Nitrogen Species; Reactive Oxygen Species; Thiazolidinediones; Vasoconstriction; Vasodilation; Vasodilator Agents | 2014 |
Effect of ruthenium red, a ryanodine receptor antagonist in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats.
Topics: Animals; Aorta; Blood Glucose; Body Weight; Brain; Calcium Channel Blockers; Dementia; Diabetes Mellitus, Experimental; Disease Models, Animal; Endothelial Cells; Male; Maze Learning; Nitrates; Nitrites; Pancreatectomy; Pioglitazone; Rats; Rats, Wistar; Reaction Time; Ruthenium Red; Ryanodine Receptor Calcium Release Channel; Thiazolidinediones | 2016 |
Effect of pioglitazone and simvastatin in lipopolysaccharide-induced amyloidogenesis and cognitive impairment in mice: possible role of glutamatergic pathway and oxidative stress.
Topics: Amyloid beta-Peptides; Animals; Cerebral Cortex; Cognitive Dysfunction; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Glutamic Acid; Lipopolysaccharides; Male; Maze Learning; Mice; Neuroprotective Agents; Nitrates; Oxidative Stress; Peptide Fragments; Pioglitazone; Recognition, Psychology; Signal Transduction; Simvastatin | 2019 |